Newgen Software Technologies (NEWGEN) — Investment Thesis

Status: OWNED (200 shares, avg ₹447.8, ~6% of portfolio)

Quality Score: 18/25 (Grade B+)

Classification: Multi-Bagger Candidate

Last Updated: 2026-04-19 | CMP: ₹484 | Entry: ₹447.8 | P&L: +8.1%

> Recommendation: HOLD. Add aggressively below ₹430.

> Newgen is the only listed Indian software product company competing globally in enterprise workflow automation — a market where switching costs are measured in years of embedded processes, not months of migration effort. At 21x earnings on a 33% profit CAGR (5-year), the market is pricing in AI-driven demand destruction that hasn't materialised. The underlying platform keeps winning global bank and insurer deals. Base case: ₹900–1,000 over 3 years (2x from CMP). Critical catalyst: Q4 FY26 results May 5, 2026 — if revenue ≥₹430 Cr and OPM ≥28%, growth re-acceleration is confirmed and the stock re-rates.

Summary Verdict

Why this business?

India has hundreds of IT services companies that sell developer hours. Newgen is something rarer: a company that owns a product — a software platform that banks and insurers in 70+ countries use to run core business workflows like loan origination, trade finance, claims processing, and regulatory compliance. Once a bank embeds Newgen into these processes, replacing it isn't a technology decision — it's a multi-year operational risk. Every teller, relationship manager, and compliance officer has been trained on it. This is why Newgen's customer retention is near 100%, why 68% of revenue is annuity-based (recurring maintenance + SaaS contracts), and why the company has compounded profits at 33% CAGR over 5 years while remaining almost entirely debt-free. The stock is down 48% from its peak because FY26 showed revenue deceleration — but quarterly data reveals this is Q1 seasonality (enterprise software deals always close in March and September) compounded by AI-driven deal elongation (CIOs pausing to decide if AI replaces workflow software). The bet here is that workflow automation and AI are complements, not substitutes — and the market will recognise this when Q4 FY26 results confirm growth has resumed.

Strengths

1. Genuine enterprise moat. BPM (Business Process Management) software embedded in core banking operations has switching costs measured in years. Newgen's workflow automation handles loan origination, KYC, trade finance — processes where a failed migration costs a bank tens of crores in operational disruption. This is not a nice-to-have tool; it is load-bearing infrastructure.

2. 33% profit CAGR over 5 years, 10-year revenue CAGR of 17%. These aren't inflated by one good year — they reflect consistent execution across geographies and economic cycles. ROCE of 28% means every rupee reinvested into the business generates 28 paise of operating profit. Most Indian IT services companies generate 18-22% ROCE on far lower growth.

3. Annuity revenue at 68% — cash flow is structurally predictable. Annual Technical Support (ATS), Annual Maintenance Contracts (AMC), and SaaS subscriptions make up 68% of revenue. Subscription revenue grew 29% YoY in 9M FY26 — accelerating even as total revenue decelerated. This is the SaaS transition playing out.

4. Global reach, Indian cost base. EMEA contributes 32% of revenue, US 21% (growing 21% YoY), APAC 16%, India 31%. Newgen is genuinely multinational — winning deals against ServiceNow and Pegasystems in their home markets — while paying Indian developer salaries. This structural cost advantage doesn't exist for any Indian IT services peer.

5. Balance sheet is a hidden asset. Investments of ₹508 Cr + near-zero debt (D/E: 0.04x). At ₹6,881 Cr market cap, roughly 7% of the market cap is liquid investments. Subtract ₹508 Cr and you're buying the operating business at ~₹6,373 Cr — P/E drops from 21x to ~19.5x on TTM PAT.

Concerns

1. AI deal elongation is real — management confirmed it. In the Q3 FY26 concall (Jan 2026), management acknowledged that enterprise CIOs are pausing large deals to evaluate how AI changes workflow automation. This is not existential — Newgen is already building AI features into its platform — but it is a 2-4 quarter headwind on new deal velocity.

2. Q1 seasonality is extreme and often misread as deterioration. Q1 FY26 OPM was 14% vs Q4 FY25 at 32%. This happens every year in enterprise software — large deals close in the March and September fiscal year-ends of customers. Q1 (June) is structurally weak. The market repeatedly sells NEWGEN at June results and this creates entry opportunities.

3. Promoter stake declining. Diwakar Nigam (founder) has reduced from 66% in 2018 to 53.52% today. Not a red flag yet, but a trend to watch. Founders reducing below 50% changes governance dynamics in Indian family-run software companies.

4. Qatar litigation. Court ordered Newgen to pay USD 1.37 million + QAR 200,000 (Apr 2026). Small in absolute terms (~₹12 Cr) but signals international execution risk on government contracts.

5. FII holding at 14.48% (down from ~17% in Dec 2025). Some institutional selling in recent months. Could be portfolio rebalancing or early concern about AI risk — worth monitoring.

The Compounding Equation

Newgen's growth engine is elegant in its simplicity. The company earns 28% ROCE on capital employed — meaning every ₹100 of capital generates ₹28 of operating profit. It is nearly debt-free and reinvests primarily through people (software engineers, sales teams, R&D) — expenses that flow through the P&L as opex, not capex. This is why CapEx is only ₹23 Cr against ₹1,552 Cr of revenue: the asset that generates value is intellectual (platform code, customer relationships, 17 verticals of domain logic) rather than physical.

Incremental ROIC (FY22→FY25): Change in NOPAT = ₹315 Cr − ₹164 Cr = ₹151 Cr. Change in Capital Employed ≈ ₹645 Cr. Incremental ROIC ≈ 23% — high enough to compound intrinsic value significantly above cost of capital.

The SaaS transition amplifies this. Subscription revenue growing at 29% YoY means recurring revenue will be a larger share of the mix each year — reducing earnings volatility, improving FCF conversion, and warranting a higher P/E multiple over time. If Newgen's revenue mix shifts from 68% annuity to 80% annuity by FY28, the business looks more like an Indian SaaS compounder and less like a project-driven IT company — a re-rating event independent of earnings growth.

What does the market think — and where do I disagree?

At ₹484 and ₹6,881 Cr market cap, the market is implying roughly 12-14% long-term earnings growth — barely above India nominal GDP. For a company that compounded profits at 33% for 5 years and is growing subscription revenue at 29%, this is a dramatic underestimation. The market's fear: AI makes workflow automation obsolete, Newgen loses pricing power, growth collapses to 10-12%.

My view: Workflow automation and AI are not substitutes. A bank doesn't replace its loan origination workflow engine with ChatGPT. It uses AI to make the workflow smarter (auto-populate fields, flag anomalies, suggest decisions) — and Newgen is the platform that houses those workflows. Newgen already integrates AI into its NewgenONE platform. The real risk is deal timing (CIOs pausing to plan AI integration), not demand destruction. Once CIOs resolve their AI strategy (12-18 months), deal velocity should normalise.

Reverse DCF: at ₹484 and TTM PAT ₹303 Cr, the market implies ~14% earnings growth perpetually at 12% discount rate. Base case reality: 20-22% earnings growth (decelerating from 33% but still strong). The gap between 14% implied and 20-22% actual is where the return comes from.

Multi-Bagger Math

Probability-weighted fair value: ~₹1,000 (2x from CMP). Shares outstanding: ~14.22 Cr (diluted).

Bear case assumes AI genuinely disrupts workflow automation demand, growth collapses and multiples compress. Base case assumes AI causes 2-4 quarter delay, then normalises. Bull case assumes AI integration makes Newgen's platform stickier, accelerating US and EMEA wins.

When do I sell?

• Revenue growth falls below 10% for 2 consecutive quarters — signals structural demand loss, not seasonality
• OPM falls below 20% consistently — margin compression from pricing pressure (competitive threat from ServiceNow/low-cost entrants)
• Subscription revenue growth decelerates below 15% — the SaaS transition is the core long-term re-rating driver; if it stalls, the thesis changes
• Stock price above ₹1,400 — at 35x+ P/E on FY29E earnings, most of the re-rating is done; trim and redeploy

Where does this rank vs portfolio alternatives?

• vs KAYNES (Grade A, EMS): Kaynes has higher ROIC (34%) and clearer runway, but is more cyclically exposed to defence/electronics order flows. NEWGEN is more predictable. Both are core holdings.
• vs ICICIAMC (Grade A, AMC): ICICIAMC is the safer compounder — less AI risk, pure AUM-fee model. But NEWGEN has higher earnings CAGR and more re-rating potential. Different risk profiles.
• vs EPACKPEB (Grade B, PEB): EPACKPEB has more binary risk (capex cycle dependent) but 2-3x the earnings growth potential. NEWGEN is the steadier compounder in the portfolio.

Action Table

1. Business Summary

Newgen Software Technologies (NSE: NEWGEN) is a Noida-based enterprise software product company founded in 1992 by Diwakar Nigam. It builds and sells a unified low-code/no-code platform called NewgenONE that enables large organisations — primarily banks, insurance companies, and government agencies — to design, automate, and manage complex business workflows. Think of it as the operating system for how a bank processes a loan, or how an insurer handles a claim: documents flow in, rules are applied, decisions are made, compliance is tracked — all on Newgen's platform.

The company operates across 17 verticals in 70+ countries. Revenue is split between product licenses (new customers, one-time), annuity contracts (ATS/AMC — annual maintenance on existing deployments), SaaS subscriptions (cloud-hosted Newgen), and professional services (implementation). The shift toward SaaS and annuity revenue is the most important structural transition underway.

Key distinction from Indian IT peers: Newgen is a product company, not a services company. It does not sell developer hours. It sells access to its platform and earns margins accordingly — 25-28% OPM vs 15-18% for typical Indian IT services firms. Competitors are global: ServiceNow, Pegasystems, Appian, and IBM's BPM suite. Newgen competes in their markets and wins — which is exceptional for an Indian software company.

2. Quality Score

3. Key Metrics

P&L (Annual)

TTM deceleration reflects cyclical AI-driven deal pause + Q1 seasonality. FY25 growth was 15% — below 5Y trend but still growing.

Quarterly Trend (last 6 quarters)

Q3 FY26 adjusted PAT (ex-labor code one-time): ~₹98 Cr = +10% YoY vs ₹89 Cr. Underlying business is growing.

Balance Sheet

Key CAGRs

PAT CAGR outpaces revenue CAGR — margin expansion is structural, not one-time.

4. Outlook

Near-term (FY26-FY27): Deceleration then re-acceleration

FY26 will likely show ~10-12% revenue growth — a deceleration from the 5-year average — driven by two factors:

1. AI deal elongation: Enterprise CIOs are pausing large BPM decisions pending their AI integration strategy. Management guided this is a 2-4 quarter delay, not cancellation.

2. Q1 seasonality: Q1 FY26 (₹321 Cr, 14% OPM) was structurally weak, dragging the full-year run-rate.

The critical data point is Q4 FY26 (May 5, 2026 results). Q4 is historically the strongest quarter (₹430 Cr in Q4 FY25). If Q4 FY26 prints ₹440+ Cr with OPM ≥28%, the growth trajectory is intact and the market should re-rate the stock toward 25-28x P/E.

Medium-term (FY28-FY29): US expansion is the growth engine

US revenue growing 21% YoY is the most significant development in NEWGEN's recent results. The US enterprise software market is 10x India — even 1% additional penetration is transformative for a company this size. Key enablers:

• US banks and insurers are accelerating digital transformation post-COVID
• Newgen's low-code/no-code pitch resonates with enterprises trying to reduce developer dependency
• Geographic diversification reduces India + Middle East customer concentration risk

AI — Complement, Not Substitute

The market's fear: ChatGPT-style AI replaces workflow automation, reducing Newgen's TAM. The reality: AI needs a workflow to operate in. A loan approval AI still requires a loan origination workflow — with human checkpoints, regulatory compliance, document management, audit trails. Newgen's platform is the container; AI is a component within it. NewgenONE already integrates AI models for document classification, fraud detection, and auto-decisioning. The risk is not obsolescence but potential commoditisation of simpler workflow tools — which Newgen avoids by operating at the complex end (banking regulatory compliance, not simple form automation).

5. Valuation

DCF (Base Case)

Assumptions: FY26E PAT ₹280 Cr (deceleration year), recovery to 18% CAGR FY27-FY29, terminal growth 8% (global software platform), discount rate 13%

Terminal Value = ₹405 Cr × 1.08 / (0.13 - 0.08) = ₹8,748 Cr

PV of FCFs (5yr) ≈ ₹870 Cr

PV of Terminal Value ≈ ₹4,750 Cr

Total intrinsic value ≈ ₹5,620 Cr + ₹508 Cr investments = ₹6,128 Cr → ₹431/share

Base DCF implies fair value ~₹430-450 — the stock at ₹484 is modestly above DCF fair value on conservative assumptions. The upside comes from multiple re-rating (18-22x → 28-30x) as SaaS mix increases and growth resumes, not from the DCF.

P/E-Based Valuation (Primary Method for Software)

DCF undervalues software companies because it uses FCF conservatively and doesn't capture the optionality of a platform business expanding globally. P/E on forward earnings is the right primary method here:

14.22 Cr diluted shares. Exit P/E 28x for base = inline with ServiceNow/Pegasystems at similar growth stages. 35x bull requires US breakout + AI integration premium.

Bear case floor: ₹405. If you believe AI causes meaningful Newgen demand destruction (not just delay), bear case is near current CMP. This is the key risk to size against.

6. Competitive Landscape

Market Position

Newgen operates in the BPM (Business Process Management) and ECM (Enterprise Content Management) software segment, competing globally against companies that are 10-100x larger. Its differentiation:

• Price: Significantly cheaper than ServiceNow/Pegasystems for comparable functionality — important in Middle East, Africa, APAC, and emerging market banks
• Domain depth: 17 verticals of pre-built industry logic — a bank deploying Newgen gets banking-specific workflows out of the box; ServiceNow's financial services module is more generic
• Implementation speed: Low-code configuration vs heavy custom development = faster time-to-value

Peer Comparison

Key insight: Newgen generates 28% ROCE with 25% OPM — better than most Indian IT peers — yet trades at 21x vs 38-44x for comparable quality Indian IT companies. The discount is entirely AI-fear driven.

7. Risks

8. Exit Triggers

• [ ] Revenue growth below 10% for 2 consecutive quarters (post-Q1 seasonality adjustment)
• [ ] OPM falls below 20% consistently — margin compression from competition
• [ ] Subscription revenue growth decelerates below 15% — SaaS transition stalling
• [ ] Promoter stake drops below 50% via open market sales
• [ ] Stock above ₹1,400 — 35x+ P/E on FY29E, most value realised

9. Review Schedule

• Q4 FY26 results: May 5, 2026 — CRITICAL. Revenue ≥₹430 Cr = thesis intact. Below ₹380 Cr = revisit bear case.
• Annual review: April 2027 — after full FY27 results; reassess CAGR trajectory
• Watch monthly: Subscription revenue disclosure, FII holding trend, any AI-BPM displacement news

11. Research Log

Most recent first.

2026-04-19 — Full research rewrite

Source: Screener.in consolidated (Apr 17, 2026) + Q3 FY26 concall notes from TODO + template rewrite

Key new findings vs Quick Summary (Mar 2026):

• FII holding at 14.48% — down from 17.34% noted earlier. Some institutional selling has occurred. Not alarming but monitor.
• Qatar court order (Apr 2026): USD 1.37M + QAR 200K. Small (~₹12 Cr) but signals international government contract execution risk.
• Q3 FY26 PAT (₹63 Cr) depressed by ₹35 Cr one-time labor code provision — adjusted ₹98 Cr = +10% YoY. The underlying business grew, the headline misled.
• ₹508 Cr investments on balance sheet = meaningful hidden asset (7% of market cap in liquid form).
• Subscription revenue growing 29% YoY in 9M FY26 — the SaaS transition is accelerating even as deal velocity slows. This is the most important long-term signal.
• US revenue growing 21% YoY — strongest geography, largest TAM, early innings.
• Base DCF fair value ₹430-450 (conservative); P/E based fair value ₹965 (base, FY29). Multiple re-rating from 21x → 28x is the primary return driver, not just earnings growth.
• Quality Score confirmed at 18/25 (Grade B+). Financials score raised to 5/5 (best-in-class balance sheet and ROIC for Indian software product companies). Valuation score at 2/5 — not cheap in absolute terms.

Thesis summary: The core bet is that AI delays (not destroys) BPM demand, Q4 FY26 confirms re-acceleration, and the market re-rates NEWGEN from 21x toward 28x as the SaaS transition becomes undeniable. Bear case downside (₹405, -16%) is manageable against base case upside (₹965, +99%). Hold full position, add aggressively below ₹430.

2026-03-12 — Initial thesis (Quick Summary)

• Entry ₹447.8. Thesis: 52% drawdown on AI fear, 33% profit CAGR, P/E 19.8x = value entry.
• See research/archive/NEWGEN_v2.md for original Quick Summary.